(Q53294142)

13 May 2018

reason for preferred rank

title

(−)-Epigallocatechin 3-gallate (EGCG) at the ocular surface inhibits corneal neovascularization (English)

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

9 August 2024

(-)-Epigallocatechin 3-gallate (EGCG) at the ocular surface inhibits corneal neovascularization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20971568

9 August 2024

1 reference

Valeria Sanchez-Huerta

1

object named as

V. Sánchez-Huerta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20971568

9 August 2024

author name string

L. Gutiérrez-Sánchez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20971568

9 August 2024

J. Flores-Estrada

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20971568

9 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20971568

9 August 2024

publication date

23 October 2010

1 reference

13 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0306987710003865?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

https://api.elsevier.com/content/article/PII:S0306987710003865?httpAccept=text/plain

9 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

9 August 2024

1 reference

13 May 2018

volume

76

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

311-313

1 reference

13 May 2018

Corneal neovascularization

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Immune privilege and angiogenic privilege of the cornea

9 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo

9 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist

9 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Inhibition by a selective IkappaB kinase-2 inhibitor of interleukin-1-induced collagen degradation by corneal fibroblasts in three-dimensional culture

9 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization

9 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Antioxidant chemistry of green tea catechins. Identification of products of the reaction of (-)-epigallocatechin gallate with peroxyl radicals

9 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis

9 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Green tea: Health benefits as cancer preventive for humans

9 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Effects of green tea and EGCG on cardiovascular and metabolic health

9 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG

9 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7.

9 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.

9 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells

9 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor

9 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Repressions of MMP-9 expression and NF-kappa B localization are involved in inhibition of lung carcinoma 95-D cell invasion by (-)-epigallocatechin-3-gallate

9 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Physiological concentrations of (-)-epigallocatechin-3-O-gallate (EGCg) prevent chromosomal damage induced by reactive oxygen species in WIL2-NS cells

9 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies

9 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Treatment of corneal neovascularization with dietary isoflavonoids and flavonoids

9 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo

9 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Angiogenesis inhibited by drinking tea.

9 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis

9 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Loteprednol and tobramycin in combination: a review of their impact on current treatment regimens

9 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization

9 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Topical bevacizumab therapy for corneal neovascularization

9 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy

9 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

Non-systemic delivery of topical brimonidine to the brain: a neuro-ocular tissue distribution study

9 August 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.MEHY.2010.09.020

9 August 2024

Identifiers

1 reference

13 May 2018

1 reference

13 May 2018